Credits: Canva
For weeks, Ann Malik, a 39-year-old mother of three and co-founder of two sports-related businesses, felt unwell but couldn’t identify the cause. With no significant medical history apart from mild asthma, she initially dismissed her fatigue and unease. When her doctor diagnosed her with mild anemia, she felt reassured and expected to recover with iron supplements, reports the Washington Post.
However, two months later, her condition worsened. She began experiencing anxiety, insomnia, loss of appetite, and weight loss. Suspecting depression, her physician prescribed an antidepressant, but it brought no relief. Malik started questioning why she remained unwell despite no apparent serious health concerns.
As her symptoms persisted, Malik found herself overwhelmed by an undefined but growing dread. She noticed a persistent fullness in the upper right side of her abdomen, though it wasn’t painful. Desperate for answers, she consulted an endocrinologist, suspecting a metabolic disorder, but blood tests showed nothing abnormal. The specialist attributed her symptoms to stress and suggested lifestyle changes.
Seeking alternative solutions, Malik consulted an integrative medicine practitioner who diagnosed her with “adrenal fatigue,” a controversial, non-medically recognized condition. She was advised to manage stress, adjust her diet, and take special serums. Though she tried to follow the recommendations, her health continued to decline. By May, she was experiencing severe night sweats, continued weight loss, and a persistent sense that something was terribly wrong.
In July, Malik developed a lingering cold that led to her coughing up blood. A chest X-ray revealed pneumonia in her right lung. She was prescribed antibiotics, which provided only slight relief. A month later, she coughed up blood again, prompting an emergency room visit. Another X-ray confirmed recurrent pneumonia, but her husband insisted something more serious was at play. They pushed for further testing, leading them to a pulmonologist.
A CT scan in August revealed an unusual area in her right lung. A bronchoscopy followed, allowing doctors to examine her airways and collect tissue samples. The results were shocking: Malik had non-small cell adenocarcinoma, the most common type of lung cancer.
Malik was stunned. A non-smoker with no prior indications of lung disease, she never suspected cancer. Her pulmonologist reassured her that they had hopefully caught it early. But Malik knew her symptoms had persisted for too long for this to be an early-stage diagnosis. The unexplained fullness in her abdomen now had an explanation—it was a sign of advanced cancer.
The day after her diagnosis, Malik’s health took a drastic turn. While attending her son’s preschool orientation, she developed double vision and struggled to use her hands. Assuming stress was to blame, she tried to push through. However, paramedics were called, and upon arrival at the hospital, doctors discovered she had suffered a stroke.
Further tests revealed the true extent of her illness. The lung cancer had spread extensively—to her left lung, liver, spine, hip bones, and brain. The stroke was a direct result of the cancer’s progression. Her prognosis was grim: doctors estimated she had about a month to live.
Despite the dire outlook, Malik’s medical team pursued additional testing. Given her age and non-smoking history, they suspected her cancer might be linked to a genetic mutation. A specialized test revealed that she had a ROS1 mutation, a rare genetic alteration found in 1–2% of lung cancer patients, typically younger individuals who never smoked.
This discovery was crucial. ROS1-positive cancers respond to targeted therapy, a specialized treatment that attacks cancer cells with the specific mutation while sparing healthy cells. Malik began chemotherapy, and the treatment showed positive effects. She sought further expertise at Massachusetts General Hospital, where thoracic oncologists tailored a treatment plan for her unique condition.
Contrary to the initial prognosis, Malik defied the odds. Now, a decade after her diagnosis, she looks forward to celebrating her 50th birthday. Her case underscores the importance of patient advocacy, persistence, and advancements in genetic testing for precision medicine.
Credits: Canva
Health officials are urging people to seek immediate medical help if they notice three particular symptoms appearing alongside Covid, as these could signal a more serious infection.
According to the latest data from the UK Health Security Agency (UKHSA), Covid cases have dipped slightly but remain present at “low levels” across the country. Hospital admissions have also fallen modestly, with weekly test positivity dropping to 10.3 percent from 11.9 percent the week before.
Despite the decline, people aged 85 and older continue to face the greatest risk of being hospitalised with the virus. Experts stress that identifying certain warning symptoms early can be key to preventing complications and ensuring timely treatment.
People are being urged to seek urgent medical advice if they or their child develop three specific symptoms while infected with Covid, as it may point to a more serious illness.
Health experts recommend contacting a GP or calling for medical assistance if symptoms such as a rash, loss of appetite, or unusual weakness appear. Immediate help is also advised if a high temperature of 38°C or above lasts for five days or fails to reduce with paracetamol.
Medical attention is further encouraged if symptoms worsen, show no improvement, or if you are unsure how to manage them. For infants, extra caution is necessary as any baby under three months old with a temperature of 38°C or higher, or a child aged three to six months with a temperature above 39°C, should be assessed by a healthcare professional.
The eligibility rules for Covid booster vaccines have been updated for the current autumn rollout. While earlier boosters were offered to people aged 65 and above and those with certain long-term conditions, this year’s criteria have been made more specific.
Those eligible for the latest booster include:
A new COVID-19 strain known as Stratus, officially labeled XFG, has begun to circulate globally. First identified in Southeast Asia in January 2025, the variant quickly spread across 38 countries by mid-year. The World Health Organization (WHO) has classified Stratus as a “variant under monitoring,” meaning it is being closely studied to understand its transmission rate, symptom pattern, and potential health impact.
For most people, especially those who are vaccinated or boosted, Stratus infections appear to be mild to moderate. Still, recognising its symptoms early remains important.
The most common signs include:
Credits: CANVA
Atorvastatin Recall 2025: Statins have long been the first-line treatment for high cholesterol, but the Food and Drug Administration (FDA) has confirmed a nationwide recall of over 140,000 bottles of a cholesterol-lowering medication. Officials flagged that some pills may not dissolve properly after ingestion, potentially reducing effectiveness for patients who rely on them daily.
The recall affects Atorvastatin Calcium, the generic version of Lipitor, which is taken by roughly 39 million Americans, most of them adults over 40, according to Dr. Tamanna Singh of the Cleveland Clinic. Federal records show that the recalled batches were manufactured by Alkem Laboratories and distributed by Ascend Laboratories in New Jersey. The FDA’s September 19 enforcement report found that several batches failed quality tests designed to ensure proper dissolution of the pills.
If the pills dissolve inconsistently or more slowly than intended, the medication may not deliver the expected cholesterol-lowering effect. The FDA classified the recall as a Class II action, indicating moderate concern. While temporary or reversible side effects could occur, the likelihood of serious harm is low.
The recall covers multiple strengths and bottle sizes of Atorvastatin Calcium Tablets, which are among the most commonly prescribed statins globally. Affected formulations include:
If you are affected by the recall, there are several alternatives to help manage cholesterol levels effectively:
Ezetimibe is often recommended when a statin alone doesn’t sufficiently lower cholesterol. It may be used if you are on the maximum statin dose but your cholesterol remains high, or alongside statins such as atorvastatin or simvastatin for conditions like homozygous familial hypercholesterolemia.
Ezetimibe works by blocking cholesterol absorption in the small intestine, causing the body to use up more cholesterol from the blood. It is one of the few non-statin medications that can further reduce LDL cholesterol, either alone or combined with statins or other alternatives.
Fibrates mainly target high triglyceride levels, a type of fat in the blood linked to heart disease and pancreatitis, and can also mildly lower LDL cholesterol. They can be taken alone, with ezetimibe, or with a statin. However, combining gemfibrozil with a statin may increase side effects, so caution is advised.
Bile acid sequestrants lower cholesterol by binding bile acids in the intestine, preventing their reabsorption. The liver then uses more cholesterol from the blood to produce new bile acids, reducing LDL cholesterol.
Potential drawbacks include:
Credits: Canva
Imagine sitting down to a juicy, perfectly cooked steak on a warm evening, and hours later you’re hit with terrible stomach cramps, itchy hives, and swelling so bad you might need to rush to the ER. The weird part? It’s not food poisoning, and the steak wasn’t bad. What’s actually happening is your own immune system is reacting, because of a tiny tick bite you got weeks or even months ago, one you probably don’t even remember.
Alpha-gal syndrome is a food allergy that can develop after a tick bite, leading to allergic reactions to red meat and products made from it. While several types of ticks can trigger it, the lone star tick is the most common culprit. Not everyone who gets bitten will develop the allergy, but repeated bites can increase the risk or worsen symptoms, as per Cleveland Clinic.
You may have an allergic reaction to:
Alpha-gal is a sugar molecule found in most mammals (except humans) and in tick saliva. Not everyone who is bitten by a tick develops alpha-gal syndrome, and you might not react to every food or product that contains it.
Alpha-gal syndrome can cause reactions ranging from mild to life-threatening. Common symptoms include:
Unlike most food allergies, reactions to alpha-gal can occur two to six hours after eating meat or dairy. Medications containing alpha-gal may trigger a faster reaction.
Alpha-gal syndrome develops after a tick bite, most commonly from the lone star tick, though bites from black-legged (deer) ticks and other species can also cause it. Ticks carry alpha-gal molecules in their saliva, and exposure during a bite can make your immune system recognize alpha-gal as a threat, triggering an allergy.
Experts aren’t certain why some people develop the allergy while others do not. Repeated tick bites can worsen symptoms or make reactions more frequent.
The lone star tick is a tiny bug, sometimes as small as a poppy seed. Adult female lone star ticks are easy to identify by the white dot on their backs, the “lone star.” They are commonly found in and around wooded areas across the Midwestern and Eastern United States.
Having alpha-gal syndrome is not just about giving up burgers or steaks. Like other food allergies, it can affect a range of products you may need to avoid. While caution is important, most people with AGS won’t react to every item that contains alpha-gal, and for some, symptoms may improve within a few years. Your healthcare provider can guide you on which foods to steer clear of and what to expect in your individual case.
© 2024 Bennett, Coleman & Company Limited